International Liver Surgery Outcomes Study

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Liver Diseases
Interventions
PROCEDURE

Liver surgery

"All indications (including benign and living donor resections), all co-morbidities, open, laparoscopic or robotic, single wedge resections to extended liver resections, single or two-stage hepatectomies, procedures with liver volume enhancement such as portal vein embolization (PVE), portal vein ligation (PVL), Associating Liver Partition and Portal vein Ligation for Staged hepatectomy (ALPPS), resections involving cold perfusion (ex-situ and ante-situ)"

Trial Locations (2)

50009

University of Zaragoza, Spain, Zaragoza

NW3 2QG

Royal Free Hospital, London

All Listed Sponsors
collaborator

Hospital Miguel Servet

OTHER

lead

Royal Free Hospital NHS Foundation Trust

OTHER

NCT03768141 - International Liver Surgery Outcomes Study | Biotech Hunter | Biotech Hunter